首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1736697

全球棘突間活動式支架市場規模（按產品、應用、最終用戶、區域範圍和預測）

Global Interspinous Spacers Market Size By Product, By Application, By End-User, By Geographic Scope And Forecast

出版日期: 2025年05月06日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

棘突間活動式支架的市場規模及預測

2024 年棘突間活動式支架市場規模價值 8,470 萬美元，預計到 2032 年將達到 1.232 億美元，2026 年至 2032 年的複合年成長率為 5.29%。

推動全球棘突間活動式支架市場的因素

棘突間活動式支架的市場驅動力受到多種因素的影響，其中包括：

人口老化：隨著世界人口老化，脊椎狹窄等退化性脊椎疾病的發生率將會上升。由於這一人口趨勢，對棘突間活動式支架等治療方法的需求將會增加。

神經系統疾病發病率不斷上升：久坐不動的生活方式、肥胖和生活方式的改變導致被診斷患有脊柱疾病的患者數量增加，從而增加了對棘突間活動式支架的需求。

技術發展包括：醫療技術的進步促成了更有效率、侵入性更小的棘突棘突間活動式支架的研發。這些技術發展正擴大被醫療保健專業人員所利用，因為它們改善了患者的治療效果並縮短了復健時間。

知識和意識的提升：隨著脊椎健康知識的普及和診斷方法的改進，越來越多的脊椎疾病將被發現和治療。旨在提高公眾意識和醫療保健可近性的宣傳活動也促進了這一趨勢。

建議手術：微創手術的優點包括恢復時間更快、併發症發生率更低，以及術後患者和醫護人員的疼痛減輕。間歇性間隔器市場的成長正是由此類選擇的適用性所推動的。

醫療成本不斷上漲：全球醫療支出不斷增加，使得包括棘突間活動式支架在內的尖端治療方法和技術更容易獲得，尤其是在醫療體系發達的已開發國家。

積極的報銷政策：一些地區透過慷慨的脊椎手術及相關器械報銷計劃，鼓勵使用棘突間活動式支架等先進治療方法。這些政策有助於患者負擔這些治療費用。

脊椎外科手術設施的擴展：隨著專業脊椎外科中心的建立和現有設施的擴建，棘突間活動式支架將得到更廣泛的應用。這些中心通常著重手術流程和設備的創新。

實驗和臨床數據：正在進行的臨床試驗和研究已經證明了棘突間活動式支架的有效性和安全性，使外科醫生和患者可以更有信心地使用它們。

委員會核准：在歐洲，獲得 FDA 和 CE 標誌等組織的監管批准至關重要，因為這將提高棘突間活動式支架的可靠性並使其能夠在市場上廣泛使用。

新興市場的經濟成長：隨著新興市場的經濟成長，支持醫療保健的基礎設施也在發展，增加了對棘突間活動式支架等尖端醫療程序的需求。

限制全球棘突間活動式支架市場的因素

棘突間活動式支架市場面臨許多阻礙與挑戰，其中包括：

器械和手術費用高昂：棘突間活動式支架的費用可能高得令人望而卻步，植入所需的手術費用也同樣高昂。這筆費用可能會對患者，尤其是保險不足的患者造成不利影響。

監管障礙：新醫療設備的核准流程複雜且耗時。製造商必須遵守歐洲藥品管理局 (EMA) 和美國食品藥物管理局(FDA) 等監管機構的嚴格標準。不遵守這些要求可能會導致產品上市延遲並增加開發成本。

限制性報銷政策：國家醫療保健系統和保險公司可能僅部分資助或不提供棘突間活動式支架治療，迫使患者自掏腰包，這可能會嚴重影響採用率。

困難和調整風險：植入棘突間活動式支架所涉及的風險與下面列出的風險類似。

感染、器械移位、需要修復手術等。由於這些潛在問題，醫療保健專業人員和患者可能會猶豫是否使用這項技術。

替代醫學治療的可用性：脊椎狹窄及相關疾病可以透過多種其他方式治療，包括物理治療、藥物治療和其他外科手術（例如減壓切除術）。這些替代方案的可用性可能會限制棘突間活動式支架的商業性應用。

長期數據和臨床證據有限：早期研究對棘突間活動式支架的療效頗有展望，但目前可能仍缺乏全面的長期證據來比較其與其他療法的安全性和有效性。如果沒有確切的長期臨床證據，醫護人員可能不願意提案治療方案。

手術技術難度：棘突間活動式支架植入術的效果高度依賴外科醫師的專業知識和經驗。手術技術的差異可能會影響療效，而該手術的技術難度也可能阻礙其推廣應用。

患者選擇標準：棘突間活動式支架並非適用於所有脊椎狹窄患者。患者選擇可能需要謹慎，這可能會減少可用的患者群體，阻礙市場擴張。

經濟方面和資金限制：由於資金問題和醫療預算限制，新醫療技術可能無法立即應用。精打細算的醫院和醫療機構可能會猶豫是否要購買昂貴的新設備。

來自老字型大小企業的競爭：脊椎移植市場中老牌企業的存在，對新進者來說可能是一個嚴重的障礙。由於老牌企業擁有成熟的經銷網路、強大的市場影響和忠實的消費群，新產品的上市之路可能充滿挑戰。

Suggested Procedures: Benefits from minimally invasive surgical procedures include shorter recovery times, lower chance of complications, and less pain after surgery for both patients and healthcare professionals. The market expansion of intermittent spacers is fueled by their good fit within this choice.

Rising Cost of Healthcare: Global healthcare spending is rising, which makes cutting-edge therapies and technologies-including interspinous spacers-more accessible. This matters especially in industrialized nations with strong healthcare systems.

Positive Reimbursement Policies: Advanced therapies like interspinous spacers are encouraged in some areas by generous payment schemes for spinal operations and related equipment. Patients may now afford to have these therapies thanks to these regulations.

Expanding Number of Spinal Surgery Facilities: Interspinous spacers are more widely available and used when specialist spinal surgical centres are established and current facilities are expanded. Many times, the emphasis of these centres is on innovative procedures and equipment.

Experimental and Clinical Data: Interspinous spacers are more confidently used by surgeons and patients because of the evidence of their effectiveness and safety provided by ongoing clinical trials and research.

Commission Approvals: It is imperative to obtain regulatory clearances from organisations like the FDA and CE marking in Europe. Approved successfully, interspinous spacers become more credible and widely available in the market.

Growth of the Economy in Emerging Markets: As emerging markets' economies grow, so does the infrastructure supporting healthcare and the need for cutting-edge medical procedures like interspinous spacers.

Global Interspinous Spacers Market Restraints

Several factors can act as restraints or challenges for the Interspinous Spacers Market. These may include:

Exorbitant Cost of Equipment and Procedures: Interspinous spacers can be highly expensive, as can the surgical procedures needed to implant them. This cost burden may discourage patients from pursuing these treatments, particularly those who lack sufficient insurance coverage.

Regulatory Obstacles: New medical device approval procedures can be difficult and time-consuming to complete. Manufacturers are subject to strict standards from regulatory agencies like the European Medicines Agency (EMA) in Europe and the Food and Drug Administration (FDA) in the United States. Failure to comply with these requirements can cause delays in entering the market and raise development costs.

Restricted Policies for Reimbursement: It's possible that national healthcare systems and insurance firms will only partially or not fund interspinous spacer treatments. Patients may be required to pay for these out of pocket, which could have a substantial influence on the adoption rate.

Peril of Difficulties and Adjustments: The dangers associated with implanting interspinous spacers are the same as those

Associated with any Surgical Procedure: infection, device migration, and the requirement for revision procedures. Healthcare professionals and patients may be hesitant to use this technology due to these possible issues.

Accessibility of Alternative Medical Care: Spinal stenosis and associated disorders can be treated with a variety of other methods, such as physical therapy, medication, and additional surgical procedures (such as decompressive laminectomy). The commercial penetration of interspinous spacers may be restricted by the availability of these substitutes.

Limited Long-Term Data and Clinical Evidence: Although early research on interspinous spacers has been promising, comprehensive long-term evidence comparing their safety and effectiveness to alternative therapies may still be lacking. Providers of healthcare could be reluctant to suggest a course of action in the absence of solid, long-term clinical evidence.

Surgical and Technical Difficulties: The surgeon's expertise and experience play a major role in the interspinous spacer implantation procedure's outcome. Variations in surgical skill might impact results, and the procedure's technical difficulties may prevent it from being widely used.

Selection Criteria for Patients: Interspinous spacers are not appropriate for all spinal stenosis patients. Careful patient selection may be necessary, which may reduce the number of possible patients and impede market expansion.

Economic Aspects and Financial Restraints: New medical technologies may not be adopted as quickly as they may be due to financial issues and healthcare budget limits. Budget-conscious hospitals and healthcare organizations could be hesitant to purchase pricey new equipment.

Competition from Well-Established Entities: For new entries into the spinal implant market, the existence of established firms can be a serious obstacle. It can be challenging for new items to take off when there are established distribution networks, strong market presence, and devoted consumer bases.

Global Interspinous Spacers Market: Segmentation Analysis

The Global Interspinous Spacers Market is segmented on the basis of Product, Application, End-User, And Geography.

Interspinous Spacers Market, By Product

Static (non-compressible spacers)
Dynamic (compressible spacers)

Based on Product, The market is bifurcated into Static (non-compressible spacers) and Dynamic (compressible spacers). The static or non-compressible spacers segment dominated the Global Interspinous Spacers Market. The cheap cost of static spacers supports its growth. The Interspinous Spacers Market, on the other hand, is expected to develop significantly during the projected period due to significant therapeutic effects and a low failure rate.

Interspinous Spacers Market, By Application

Lumbar Spinal Stenosis
Degenerative Disc Diseases
Others

Based on Applications, The market is bifurcated into Lumbar Spinal Stenosis, Degenerative Disc Diseases, and Others.

Interspinous Spacers Market, By End-User

Hospitals
Orthopedic Clinics
Ambulatory Surgery Centers

Based on End-User, The market is bifurcated into Hospitals, Orthopedic Clinics, and Ambulatory Surgery Centers. The Hospitals segment dominated the market. The increased rate of hospitalization for spinal injuries and disorders, advancements in in-hospital treatment, and accessibility of a broad array of services at hospitals are some of the primary drivers for this position, saving patients the inconvenience of visiting specialty clinics or independent experts.

Interspinous Spacers Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, the Global Interspinous Spacers Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Due to a rise in the geriatric population, increasing incidence of lumbar spinal stenosis and degenerative disc diseases, rising healthcare investments, rising per capita income, improving healthcare infrastructure, and growing healthcare expenditure, Asia Pacific is expected to drive the market.

Key Players

The major players in the Interspinous Spacers Market are:
Medtronic
Zimmer Biomet
Boston Scientific
NuVasive Inc.
Globus Medical Inc.
Paradigm Spine (RTI Surgical)
Vertiflex Inc.
Life Spine Inc.
Synthes GmbH
Mikai S.p.A and Alphatec Spine Inc.

1 INTRODUCTION OF GLOBAL INTERSPINOUS SPACERS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL INTERSPINOUS SPACERS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL INTERSPINOUS SPACERS MARKET, BY PRODUCT

5.1 Overview
5.2 Static (non-compressible spacers)
5.3 Dynamic (compressible spacers)

6 GLOBAL INTERSPINOUS SPACERS MARKET, BY APPLICATIONS

6.1 Overview
6.2 Lumbar Spinal Stenosis
6.3 Degenerative Disc Diseases
6.4 Others

7 GLOBAL INTERSPINOUS SPACERS MARKET, BY END-USER

7.1 Overview
7.2 Hospitals
7.3 Orthopedic Clinics
7.4 Ambulatory Surgery Centers

8 GLOBAL INTERSPINOUS SPACERS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East & Africa

9 GLOBAL INTERSPINOUS SPACERS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Medtronic
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Zimmer Biomet
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Boston Scientific
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 NuVasive Inc.
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Globus Medical Inc.
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Paradigm Spine (RTI Surgical)
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Vertiflex Inc.
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Life Spine Inc.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Synthes GmbH
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Mikai S.p.A.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
10.11 Alphatec Spine Inc.
- 10.11.1 Overview
- 10.11.2 Financial Performance
- 10.11.3 Product Outlook
- 10.11.4 Key Developments